PUBLICATIONS · 22715121
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2012 Aug 23
- First author
- Iland HJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Blood. 2012 Aug 23;120(8):1535-6. doi: 10.1182/blood-2012-07-439547.
- note
- Source null
- related pmid
- 22918418
- relationship
- Comment in
Authors and identifiers
- name
- Iland HJ
- type
- Author
- name
- Bradstock K
- type
- Author
- name
- Supple SG
- type
- Author
- name
- Catalano A
- type
- Author
- name
- Collins M
- type
- Author
- name
- Hertzberg M
- type
- Author
- name
- Browett P
- type
- Author
- name
- Grigg A
- type
- Author
- name
- Firkin F
- type
- Author
- name
- Hugman A
- type
- Author
- name
- Reynolds J
- type
- Author
- name
- Di Iulio J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Iland HJ
- type
- Author
- name
- Bradstock K
- type
- Author
- name
- Supple SG
- type
- Author
- name
- Catalano A
- type
- Author
- name
- Collins M
- type
- Author
- name
- Hertzberg M
- type
- Author
- name
- Browett P
- type
- Author
- name
- Grigg A
- type
- Author
- name
- Firkin F
- type
- Author
- name
- Hugman A
- type
- Author
- name
- Reynolds J
- type
- Author
- name
- Di Iulio J
- type
- Author
- bibliography ids
- nci-bib-29b98473c116192e045016a6
- book metadata
- content sha256
- 89ce9148e99d75d9707b9b7b34fdddaa30d7015d313fe400f66ab160606af7cb
- document type
- citation
- dois
- 10.1182/blood-2012-02-410746
- electronic publication date
- display
- 2012 Jun 19
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22715121
- immutable id
- pubmed:22715121@89ce9148e99d75d9707b9b7b34fdddaa30d7015d313fe400f66ab160606af7cb
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 8
- name
- Blood
- nlm unique id
- 7603509
- pages
- 1570-80; quiz 1752
- volume
- 120
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Blood. 2012 Aug 23;120(8):1535-6. doi: 10.1182/blood-2012-07-439547.
- note
- Source null
- related pmid
- 22918418
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 22715121
- provenance
- batch id
- c95be1d0b8cf19942816
- provider
- NCBI PubMed ESummary
- record sha256
- 78863a17b7cd2920c3b83d7f999b115407e3b75d3f5bd43f1864c57dd8438d2f
- response sha256
- a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
- retrieved at
- 2026-09-09T23:46:47.691937+00:00
- publication date
- display
- 2012 Aug 23
- precision
- day
- year
- 2012
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Preserved source evidence · Not medical advice
Triangle